Noticias de KZR_US

Noticias del mercado

Últimas noticias sobre KZR_US — 56 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.

Ticker: KZR_US ✕ 56 resultados
08/04/2026 KZR_US — sonla.gov.vn
What limits growth of Kezar Life (KZR) Stock | Price at $7.38, Down 0.14% - Industry Analysis
08/04/2026 KZR_US — laocai.gov.vn
What limits growth of Kezar Life (KZR) Stock | Price at $7.38, Down 0.14% - Industry Analysis
08/04/2026 KZR_US — haiphong.gov.vn
What limits growth of Kezar Life (KZR) Stock | Price at $7.38, Down 0.14% - Momentum Picks
07/04/2026 KZR_US — Stock Titan
Are KZR, TALK, WBD Obtaining Fair Deals for their Shareholders?
06/04/2026 KZR_US — haiphong.gov.vn
KZR Q4 2025 Earnings: Kezar Life Sciences Inc. Misses EPS, No Revenue - Expert Verified Trades
06/04/2026 KZR_US — Xã Thanh Hà
KZR Q4 2025 Earnings: Kezar Life Sciences Inc. Misses EPS, No Revenue - Crowd Breakout Signals
06/04/2026 KZR_US — Stock Titan
Baselake reports 5.3% stake in Kezar Life Sciences (NASDAQ: KZR)
05/04/2026 KZR_US — Minichart ES ← EN
Kezar Life Sciences anuncia acuerdos de terminación del arrendamiento y separación de ejecutivos en abril de 2026
04/04/2026 KZR_US — Minichart ES ← EN
Aurinia Pharmaceuticals adquirirá Kezar Life Sciences por 6,96 dólares por acción más derechos de valor contingente en un acuerdo de fusión de 2026
03/04/2026 KZR_US — Investing.com
Kezar Life Sciences announces lease termination and executive departures following merger agreement
03/04/2026 KZR_US — Stock Titan
Aurinia to acquire Kezar (NASDAQ: KZR) for $6.955 cash plus CVR
03/04/2026 KZR_US — TipRanks
Kezar Life Sciences Announces Major Executive Leadership Changes
03/04/2026 KZR_US — MarketScreener
Kezar Life Sciences, Inc. Announces Resignation of Marc L. Belsky as CFO
03/04/2026 KZR_US — MarketScreener
Kezar Life Sciences, Inc. Announces Resignation of Mark Schiller as Chief Operating Office
03/04/2026 KZR_US — Stock Titan
Aurinia (NASDAQ: AUPH) to acquire Kezar with $6.955 per share cash and CVRs
03/04/2026 KZR_US — TipRanks
Aurinia Pharmaceuticals to Acquire Kezar, Expanding Autoimmune Pipeline
01/04/2026 KZR_US — Stock Titan
Major Kezar (KZR) shareholder signs merger support pact and drops bid
31/03/2026 KZR_US — Zenopa
Aurinia Pharmaceuticals to Acquire Kezar Life Sciences for $6.955 in Cash per Share Plus a Contingent Value Right
31/03/2026 KZR_US — Pulse 2.0
Aurinia Pharmaceuticals: $6.955 Per Share Acquisition Of Kezar Life Sciences To Expand Autoimmune Pipeline
30/03/2026 KZR_US — Business Wire
Aurinia Pharmaceuticals to Acquire Kezar Life Sciences for $6.955 in Cash per Share Plus a Contingent Value Right

Página 2 de 3

keyboard_arrow_up